Follow
Fakhreddin Jamali
Fakhreddin Jamali
Verified email at ualberta.ca - Homepage
Title
Cited by
Cited by
Year
Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications
S Harirforoosh, W Asghar, F Jamali
Journal of Pharmacy & Pharmaceutical Sciences 16 (5), 821-847, 2013
9932013
Enantioselective aspects of drug action and disposition: therapeutic pitfalls
F Jamali, R Mehvar, FM Pasutto
Journal of pharmaceutical sciences 78 (9), 695-715, 1989
5371989
Renal adverse effects of nonsteroidal anti-inflammatory drugs
S Harirforoosh, F Jamali
Expert opinion on drug safety 8 (6), 669-681, 2009
3502009
Clinical pharmacokinetics of ketoprofen and its enantiomers
F Jamali, DR Brocks
Clinical pharmacokinetics 19 (3), 197-217, 1990
2861990
COX-2 selective inhibitors cardiac toxicity: getting to the heart of the matter
NM Davies, F Jamali
J Pharm Pharm Sci 7 (3), 332-336, 2004
1722004
Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs
F Jamali
European journal of drug metabolism and pharmacokinetics 13 (1), 1-9, 1988
1691988
Clinical pharmacokinetics of ketorolac tromethamine
DR Brocks, F Jamali
Clinical pharmacokinetics 23 (6), 415-427, 1992
1621992
Active ingredient consistency of commercially available glucosamine sulfate products.
AS Russell, A Aghazadeh-Habashi, F Jamali
The Journal of rheumatology 29 (11), 2407-2409, 2002
1502002
Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration.
RT Foster, F Jamali
Drug Metabolism and Disposition 16 (4), 623-626, 1988
1491988
High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method
N Daneshtalab, RZ Lewanczuk, F Jamali
Journal of Chromatography B 766 (2), 345-349, 2002
1482002
Stereoselective pharmacokinetics of flurbiprofen in humans and rats
F Jamali, BW Berry, MR Tehrani, AS Russell
Journal of pharmaceutical sciences 77 (8), 666-669, 1988
1471988
The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review
W Asghar, F Jamali
Inflammopharmacology 23, 1-16, 2015
1452015
Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis
PR Mayo, K Skeith, AS Russell, F Jamali
British journal of clinical pharmacology 50 (6), 605-613, 2000
1412000
A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA study
HERA Study Group
The American Journal of Medicine 98 (2), 156-168, 1995
1361995
Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses
RT Foster, F Jamali, AS Russell, SR Alballa
Journal of pharmaceutical sciences 77 (1), 70-73, 1988
1291988
High-performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine
RT Foster, F Jamali
Journal of Chromatography B: Biomedical Sciences and Applications 416, 388-393, 1987
1261987
Protective effects of angiotensin II interruption: evidence for antiinflammatory actions
NJ Dagenais, F Jamali
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (9 …, 2005
1142005
Single dose pharmacokinetics and bioavailability of glucosamine in the rat
A Aghazadeh-Habashi, S Sattari, F Pasutto, F Jamali
J Pharm Pharm Sci 5 (2), 181-184, 2002
1132002
Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates
F Jamali, NN Singh, FM Pasutto, AS Russell, RT Coutts
Pharmaceutical research 5, 40-43, 1988
1121988
Ibuprofen racemate and enantiomers: phase diagram, solubility and thermodynamic studies
SK Dwivedi, S Sattari, F Jamali, AG Mitchell
International journal of pharmaceutics 87 (1-3), 95-104, 1992
1061992
The system can't perform the operation now. Try again later.
Articles 1–20